{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:49:09Z","timestamp":1787827749109,"version":"build-2784847793"},"reference-count":35,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005027","name":"Belgian Development Agency","doi-asserted-by":"publisher","award":["DGD_FA4"],"award-info":[{"award-number":["DGD_FA4"]}],"id":[{"id":"10.13039\/501100005027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Gambiense human African trypanosomiasis (gHAT), also known as gambiense sleeping sickness, is a parasitic infection caused by Trypanosoma brucei gambiense. During the last decades, gHAT incidence has been brought to an all-time low. Newly developed serological tools and drugs for its diagnosis and treatment put the WHO goal of interruption of transmission by 2030 within reach. However, further research is needed to efficiently adapt these new advances to new control strategies. We assessed the serological evolution of cured gHAT patients over a two-year period using four different tests: the rapid diagnostic test (RDT) HAT Sero K-SeT, ELISA\/T.b. gambiense, Trypanosoma brucei gambiense inhibition ELISA (iELISA), and the immune trypanolysis test. High seropositive rates were observed in all the tests, although sero-reversion rates were different in each test: ELISA\/T.b. gambiense was the test most likely to become negative two years after treatment, whereas RDT HAT Sero-K-SeT was the least likely. iELISA and trypanolysis showed intermediate and comparable probabilities to become negative. Stage 1 patients were also noted to be more likely to become negative than Stage 2 patients in all four serological tests. Our results confirm previous findings that trypanosome-specific antibody concentrations in blood may persist for up to two years, implying that HAT control programs should continue to take the history of past HAT episodes into consideration.<\/jats:p>","DOI":"10.3390\/diagnostics12020246","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T21:01:51Z","timestamp":1642626111000},"page":"246","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Two-Year Follow-Up of Trypanosoma brucei gambiense Serology after Successful Treatment of Human African Trypanosomiasis: Results of Four Different Sero-Diagnostic Tests"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2870-0311","authenticated-orcid":false,"given":"Raquel","family":"Inocencio da Luz","sequence":"first","affiliation":[{"name":"Unit of Mycobacterial Diseases and Neglected Tropical Diseases, Department of Public Health, Institute of Tropical Medicine, 2000 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tablado Alonso","sequence":"additional","affiliation":[{"name":"Unit of Mycobacterial Diseases and Neglected Tropical Diseases, Department of Public Health, Institute of Tropical Medicine, 2000 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"B\u00fcscher","sequence":"additional","affiliation":[{"name":"Unit of Diagnostic Parasitology, Department of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Verl\u00e9","sequence":"additional","affiliation":[{"name":"Unit of Mycobacterial Diseases and Neglected Tropical Diseases, Department of Public Health, Institute of Tropical Medicine, 2000 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-4766","authenticated-orcid":false,"given":"Anja","family":"De Weggheleire","sequence":"additional","affiliation":[{"name":"Unit of Mycobacterial Diseases and Neglected Tropical Diseases, Department of Public Health, Institute of Tropical Medicine, 2000 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5886-2004","authenticated-orcid":false,"given":"Dieudonn\u00e9","family":"Mumba Ngoyi","sequence":"additional","affiliation":[{"name":"Institut National de Recherce Biom\u00e9dicale, D\u00e9partement de Parasitologie, Kinshasa 834, Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4017-7519","authenticated-orcid":false,"given":"Pati Patient","family":"Pyana","sequence":"additional","affiliation":[{"name":"Institut National de Recherce Biom\u00e9dicale, D\u00e9partement de Parasitologie, Kinshasa 834, Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Epco","family":"Hasker","sequence":"additional","affiliation":[{"name":"Unit of Mycobacterial Diseases and Neglected Tropical Diseases, Department of Public Health, Institute of Tropical Medicine, 2000 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human African trypanosomiasis","volume":"390","author":"Cecchi","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lejon, V., Bentivoglio, M., and Franco, J.R. (2013). Human African Trypanosomiasis, Elsevier B.V.. [1st ed.].","DOI":"10.1016\/B978-0-444-53490-3.00011-X"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Jamonneau, V., Ilboudo, H., Kabor\u00e9, J., Kaba, D., Koffi, M., Solano, P., Garcia, A., Courtin, D., Laveissi\u00e8re, C., and Lingue, K. (2012). Untreated human infections by trypanosoma brucei gambiense are not 100% fatal. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001691"},{"key":"ref_4","unstructured":"World Health Organization (2021, September 27). Global Health Observatory Data Repository\u2014Number of New Reported Cases (T. b. Gambiense). Available online: https:\/\/apps.who.int\/gho\/data\/node.main.A1636?lang=en."},{"key":"ref_5","unstructured":"World Health Organization (2020). Ending the Neglected to Attain the Sustainable Development Goals: A Roadmap for Neglected Tropical Diseases 2021\u20132030, World Health Organization."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1756-3305-5-157","article-title":"Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan","volume":"5","author":"Checchi","year":"2012","journal-title":"Parasites Vectors"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Dickie, E.A., Giordani, F., Gould, M.K., M\u00e4ser, P., Burri, C., Mottram, J.C., Rao, S.P.S., and Barrett, M.P. (2020). New drugs for human African trypanosomiasis: A twenty first century success story. Trop. Med. Infect. Dis., 5.","DOI":"10.3390\/tropicalmed5010029"},{"key":"ref_8","unstructured":"(2021, December 02). Drugs for Neglected Diseases Initiative. Acoziborole|DNDi. Available online: https:\/\/dndi.org\/research-development\/portfolio\/acoziborole\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1586\/14787210.2014.959496","article-title":"Treatment options for second-stage gambiense human African trypanosomiasis","volume":"12","author":"Eperon","year":"2014","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Lumbala, C., Bi\u00e9ler, S., Kayembe, S., Makabuza, J., Ongarello, S., and Ndung\u2019u, J.M. (2018). Prospective evaluation of a rapid diagnostic test for Trypanosoma brucei gambiense infection developed using recombinant antigens. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006386"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kon\u00e9, M., Kaba, D., Kabor\u00e9, J., Thomas, L.F., Falzon, L.C., Koffi, M., Kouam\u00e9, C.M., Ahouty, B., Compaor\u00e9, C.F.A., and N\u2019Gouan, E.K. (2021). Passive surveillance of human African trypanosomiasis in C\u00f4te d\u2019Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009656"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4269\/ajtmh.2010.09-0735","article-title":"Diagnostic accuracy and feasibility of serological tests on filter paper samples for outbreak detection of T.b. gambiense human African trypanosomiasis","volume":"83","author":"Hasker","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/tmi.12316","article-title":"Immune trypanolysis test with blood spotted on filter paper for epidemiological surveillance of sleeping sickness","volume":"19","author":"Camara","year":"2014","journal-title":"Trop. Med. Int. Health"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Jamonneau, V., Bucheton, B., Kabor\u00e9, J., Ilboudo, H., Camara, O., Courtin, F., Solano, P., Kaba, D., Kambire, R., and Lingue, K. (2010). Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000917"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1051\/parasite\/2019066","article-title":"Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis","volume":"26","author":"Dama","year":"2019","journal-title":"Parasite"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0035-9203(95)90408-5","article-title":"Epidemiological evidence for immunity following Trypanosoma brucei gambiense sleeping sickness","volume":"89","author":"Khonde","year":"1995","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.meegid.2014.12.017","article-title":"Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo","volume":"30","author":"Pyana","year":"2015","journal-title":"Infect. Genet. Evol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/eva.12338","article-title":"Whole genome sequencing shows sleeping sickness relapse is due to parasite regrowth and not reinfection","volume":"9","author":"Richardson","year":"2016","journal-title":"Evol. Appl."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mudji, J., Blum, A., Grize, L., Wampfler, R., Ruf, M.T., Cnops, L., Nickel, B., Burri, C., and Blum, J. (2020). Gambiense human African trypanosomiasis sequelae after treatment: A follow-up study 12 years after treatment. Trop. Med. Infect. Dis., 5.","DOI":"10.3390\/tropicalmed5010010"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cid\/ciaa897","article-title":"Extravascular Dermal Trypanosomes in Suspected and Confirmed Cases of gambiense Human African Trypanosomiasis","volume":"73","author":"Camara","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lejon, V., Ngoyi, D.M., Boelaert, M., and B\u00fcscher, P. (2010). A CATT negative result after treatment for human african trypanosomiasis is no indication for cure. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000590"},{"key":"ref_22","first-page":"362","article-title":"Trypanosomose humaine africaine en C\u00f4te d\u2019Ivoire: Caract\u00e9ristiques biologiques apr\u00e8s traitement. A propos de 812 cas trait\u00e9s dans le foyer de Daloa (C\u00f4te d\u2019Ivoire)","volume":"95","author":"Miezan","year":"2003","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"ref_23","first-page":"213","article-title":"Utilisation du Testryp CATT pour le depistage de la trypanosomiase a Nioki, Zaire","volume":"66","author":"Pepin","year":"1986","journal-title":"Ann. Soc. Belg. Med. Trop."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0140-6736(92)90524-7","article-title":"Persistence of antibodies to Trypanosoma brucei gambiense after treatment of human trypanosomiasis in Uganda","volume":"340","author":"Paquet","year":"1992","journal-title":"Lancet"},{"key":"ref_25","first-page":"440","article-title":"L\u2019Immunofluorescence Indirecte Dans La Surveillance Therapeutique Des Trypanosomes (Note Preliminaire)","volume":"71","author":"Frezil","year":"1978","journal-title":"Bull. Soc. Pathol. Exot. Fil."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/649917","article-title":"How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness","volume":"201","author":"Ngoyi","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_27","first-page":"93","article-title":"Monitoring the use of nifurtimox-eflornithine combination therapy (NECT) in the treatment of second stage gambiense human African trypanosomiasis","volume":"3","author":"Franco","year":"2012","journal-title":"Res. Rep. Trop. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1365-3156.2003.01077.x","article-title":"Short communication: Towards saliva-based screening for sleeping sickness?","volume":"8","author":"Lejon","year":"2003","journal-title":"Trop. Med. Int. Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-3156.2006.01620.x","article-title":"Detection of trypanosome-specific antibodies in saliva, towards non-invasive serological diagnosis of sleeping sickness","volume":"11","author":"Lejon","year":"2006","journal-title":"Trop. Med. Int. Health"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e2477","DOI":"10.1093\/cid\/ciaa1264","article-title":"Trypanosoma brucei gambiense-iELISA: A Promising New Test for the Post-Elimination Monitoring of Human African Trypanosomiasis","volume":"73","author":"Geerts","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0001-706X(95)00127-Z","article-title":"Evaluation of variant specific trypanolysis tests for serodiagnosis of human infections with Trypanosoma brucei gambiense","volume":"60","author":"Magnus","year":"1995","journal-title":"Acta Trop."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12936-016-1529-6","article-title":"Performance and time to become negative after treatment of three malaria rapid diagnostic tests in low and high malaria transmission settings","volume":"15","author":"Grandesso","year":"2016","journal-title":"Malar. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The Measurement of Observer Agreement for Categorical Data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0895-4356(90)90159-M","article-title":"High Agreement but Low Kappa","volume":"43","author":"Feinstien","year":"1990","journal-title":"J. Clin. Epidemiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"da Luz, R.I., Phanzu, D.M., Kiabanzawoko, O.N., Miaka, E., Verl\u00e9, P., De Weggheleire, A., B\u00fcscher, P., Hasker, E., and Boelaert, M. (2021). Feasibility of a dried blood spot strategy for serological screening and surveillance to monitor elimination of human african trypanosomiasis in the Democratic Republic of the Congo. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009407"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/2\/246\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:04:17Z","timestamp":1760133857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/2\/246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["diagnostics12020246"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics12020246","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]}}}